Literature DB >> 15967635

Analysis of the three common mutations in the CARD15 gene (R702W, G908R and 1007fs) in South African colored patients with inflammatory bowel disease.

M G Zaahl1, T Winter, L Warnich, M J Kotze.   

Abstract

The caspase recruitment domain-containing protein 15 gene (CARD15) was recently identified as an important susceptibility gene for Crohn's disease (CD). The purpose of this study was to assess the likelihood that the three most common CARD15 mutations, R702W, G908R and 1007fs, contribute to inflammatory bowel disease (IBD) susceptibility in the South African colored population. The study cohort included 76 IBD patients, 41 with CD and 35 with ulcerative colitis (UC), and 100 population-matched controls. Mutations R702W, G908R and 1007fs were present at relatively low frequencies (<20%) in our study population. No statistically significant differences were furthermore, observed for these mutations between UC and CD patients or when compared with normal control individuals. Two additional mutations were identified, one novel (A661P) and one previously described (A725G), with the latter being identified in 4 of 35 (11%) UC patients. Statistically significant differences were obtained between UC and control individuals when comparing both allele (p<0.004, chi2 with Yates' correction=8.01) and genotype frequencies (p<0.004, chi2 with Yates' correction=8.14) for the A725G mutation, suggesting a possible role for this variant in disease expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967635     DOI: 10.1016/j.mcp.2005.03.001

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  17 in total

1.  Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation.

Authors:  Shigeki Nakagome; Shuhei Mano; Lukasz Kozlowski; Janusz M Bujnicki; Hiroki Shibata; Yasuaki Fukumaki; Judith R Kidd; Kenneth K Kidd; Shoji Kawamura; Hiroki Oota
Journal:  Mol Biol Evol       Date:  2012-01-12       Impact factor: 16.240

Review 2.  Have genomic discoveries in inflammatory bowel disease translated into clinical progress?

Authors:  Adam V Weizman; Mark S Silverberg
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 3.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 4.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

5.  Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture.

Authors:  Oloruntosin Adeyanju; David T Okou; Clifton Huang; Archana Kumar; Cary Sauer; Courtney Galloway; Mahadev Prasad; Jon Waters; David J Cutler; Michael E Zwick; Tanvi Dhere; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2012-03-22       Impact factor: 5.325

Review 6.  NOD2: ethnic and geographic differences.

Authors:  Juleen Cavanaugh
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

7.  Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.

Authors:  Billy Ray Ballard; Amosy Ephreim M'Koma
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

8.  Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Authors:  Ming-Hsi Wang; Toshihiko Okazaki; Subra Kugathasan; Judy H Cho; Kim L Isaacs; James D Lewis; Duane T Smoot; John F Valentine; Howard A Kader; Jean G Ford; Mary L Harris; Maria Oliva-Hemker; Carmen Cuffari; Michael S Torbenson; Richard H Duerr; Mark S Silverberg; John D Rioux; Kent D Taylor; Geoffrey C Nguyen; Yuqiong Wu; Lisa W Datta; Stanley Hooker; Themistocles Dassopoulos; Rick A Kittles; Linda W H Kao; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2012-03-12       Impact factor: 5.325

9.  African-American inflammatory bowel disease in a Southern U.S. health center.

Authors:  Hemanth Veluswamy; Kunal Suryawala; Ankur Sheth; Shannon Wells; Erik Salvatierra; Walter Cromer; Ganta V Chaitanya; Annette Painter; Mihir Patel; Kenneth Manas; Ellenmarie Zwank; Moheb Boktor; Kondal Baig; Balaji Datti; Michael J Mathis; Alireza Minagar; Paul A Jordan; Jonathan S Alexander
Journal:  BMC Gastroenterol       Date:  2010-09-09       Impact factor: 3.067

10.  NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.

Authors:  Themistocles Dassopoulos; Geoffrey C Nguyen; Monica Vladut Talor; Lisa Wu Datta; Kim L Isaacs; James D Lewis; Michael S Gold; John F Valentine; Duane T Smoot; Mary L Harris; Maria Oliva-Hemker; Theodore M Bayless; C Lynne Burek; Steven R Brant
Journal:  Am J Gastroenterol       Date:  2009-10-13       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.